Relatlimab (anti-LAG-3/CD223) - Primary antibody, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to LAG3/CD223, >95%, high purity, Human IgG4SP, Antibody of LAG3 (CD223)

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Features and benefits
  • Host species: Human
  • Species reactivity(Reacts with): Cynomolgus monkey,Human
  • Isotype: Human IgG4SP
  • Conjugation: Unconjugated
Item Number
Ab169321
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab169321-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$49.90
Ab169321-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$237.90
Ab169321-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$717.90
Ab169321-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,167.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameRelatlimab (anti-LAG-3/CD223) - Primary antibody, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to LAG3/CD223, >95%, high purity, Human IgG4SP
SynonymsBMS-986016 | RELA | CD223 antibody | CD223 antigen antibody | FDC protein antibody | LAG-3 antibody | Lag3 antibody | LAG3_HUMAN antibody | Lymphocyte activating 3 antibody | Lymphocyte activation gene 3 antibody | Lymphocyte activation gene 3 protein ant
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Host speciesHuman
SpecificityLAG3/CD223
ApplicationFlow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR)
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionAntibody of LAG3 (CD223)
Product Description

Relatlimab (anti-LAG-3/CD223) is a human LAG-3 specific monoclonal antibody that binds to LAG-3 on T cells, restoring effector function of exhausted T cells.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Antibody TypePrimary antibody
ClonalityRecombinant
IsotypeHuman IgG4SP
Light Chain Typekappa
SDS-PAGE27.1 kDa (Light Chain) & 53.4 kDa (Heavy Chain), under reducing conditions; 176.6 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95%
SourceCHO supernatant
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS1673516-98-7

Images

Relatlimab (anti-LAG-3/CD223) (Ab169321) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood mononuclear lymphocytes labelling LAG-3/CD223 (red) with Relatlimab (anti- LAG-3/CD223) (Ab169321). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Relatlimab (anti-LAG-3/CD223) (Ab169321) - SEC
The purity of Relatlimab (anti-LAG-3/CD223) (Ab169321) is more than 95% verified by HPLC.

Relatlimab (anti-LAG-3/CD223) (Ab169321) - ELISA
Immobilized Recombinant Human LAG-3 protein (rp176292) at 1.0 μg/mL can bind Relatlimab (anti-LAG-3/CD223) (Ab169321) with the EC₅₀ of 41.53 ng/mL.​

Associated Targets(Human)

LAG3 Tclin Lymphocyte activation gene 3 protein (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F1001433Certificate of AnalysisOct 26, 2023 Ab169321
ZJ23F1001416Certificate of AnalysisOct 26, 2023 Ab169321

Related Documents

References

1. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI et al..  (2004)  Role of LAG-3 in regulatory T cells..  Immunity,  21  (4): (503-13).  [PMID:15485628] [10.1021/op500134e]
2. Nguyen LT, Ohashi PS.  (2015)  Clinical blockade of PD1 and LAG3--potential mechanisms of action..  Nat Rev Immunol,  15  (1): (45-56).  [PMID:25534622] [10.1021/op500134e]
3. Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequignot E, Hercend T.  (1990)  LAG-3, a novel lymphocyte activation gene closely related to CD4..  J Exp Med,  171  (5): (1393-405).  [PMID:1692078] [10.1021/op500134e]
4. Baixeras, E E and 8 more authors..  (1992)  Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens..  The Journal of experimental medicine,    (1):   [PMID:1380059]
5. Huard, B B and 8 more authors..  (1997)  Characterization of the major histocompatibility complex class II binding site on LAG-3 protein..  Proceedings of the National Academy of Sciences of the United States of America,    (27):   [PMID:9159144]
6. Bruniquel, D D, Borie, N N, Hannier, S S and Triebel, F F..  (1998)  Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II..  Immunogenetics,      [PMID:9634475]
7. Scherer, Steven E SE and 216 more authors..  (2006)  The finished DNA sequence of human chromosome 12..  Nature,    (16):   [PMID:16541075]
8. Camisaschi, Chiara C and 9 more authors..  (2010)  LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:20421648]
9. Wang, Jun and 20 more authors..  (2019)  Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3..  Cell,    (10):   [PMID:30580966]

Solution Calculators